{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:26:58Z","timestamp":1794590818670,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05432-4","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:51:17Z","timestamp":1749721877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Piloting the options assessment toolkit with national malaria programme leaders from the Asia\u2013Pacific countries: a meeting report"],"prefix":"10.1186","volume":"24","author":[{"given":"Manash","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjaya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselyn","family":"Neukom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karma","family":"Lhazeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngo Duc","family":"Thang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Naeem","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndes","family":"Wini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobgyel","family":"Tobgyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesang","family":"Wangchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Rekol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lek","family":"Dysoley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siv","family":"Sovannaroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Simatuopang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Dewi","family":"Prameswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asik","family":"Surya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zau","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boualam","family":"Khamlome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Hafizi Abdul","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Kumar","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Top","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheen Angelou","family":"Juangco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Il","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Il","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumudu","family":"Gunasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Champa","family":"Aluthwera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prayuth","family":"Sudathip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungrawee","family":"Timpontree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Dinh","family":"Canh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zeeshan","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreehari","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Commons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varunika","family":"Ruwanpura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phone Si","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poe Poe","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Valecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"5432_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","volume":"394","author":"KE Battle","year":"2019","unstructured":"Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study. Lancet. 2019;394:332\u201343.","journal-title":"Lancet"},{"key":"5432_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","volume":"36","author":"RN Price","year":"2020","unstructured":"Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the era of the shrinking P. falciparum map. Trends Parasitol. 2020;36:560\u201370.","journal-title":"Trends Parasitol"},{"key":"5432_CR3","volume-title":"World malaria report 2021","author":"WHO","year":"2021","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization; 2021."},{"key":"5432_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001160","volume":"5","author":"JM Carlton","year":"2011","unstructured":"Carlton JM, Sina BJ, Adams JH. Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis. 2011;5: e1160.","journal-title":"PLoS Negl Trop Dis"},{"key":"5432_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.","journal-title":"Malar J"},{"key":"5432_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.4269\/ajtmh.20-0186","volume":"103","author":"RJ Commons","year":"2020","unstructured":"Commons RJ, Simpson JA, Watson J, White NJ, Price RN. Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis. Am J Trop Med Hyg. 2020;103:1094\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"5432_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004582","volume":"10","author":"A Ross","year":"2016","unstructured":"Ross A, Koepfli C, Schoepflin S, Timinao L, Siba P, Smith T, et al. The incidence and differential seasonal patterns of Plasmodium vivax primary infections and relapses in a cohort of children in Papua New Guinea. PLoS Negl Trop Dis. 2016;10: e0004582.","journal-title":"PLoS Negl Trop Dis"},{"key":"5432_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003561","volume":"18","author":"CS Chu","year":"2021","unstructured":"Chu CS, White NJ. The prevention and treatment of Plasmodium vivax malaria. PLoS Med. 2021;18: e1003561.","journal-title":"PLoS Med"},{"issue":"4","key":"5432_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003494","volume":"18","author":"K Thriemer","year":"2021","unstructured":"Thriemer K, Ley B, von Seidlein L. Towards the elimination of Plasmodium vivax malaria: implementing the radical cure. PLoS Med. 2021;18(4): e1003494.","journal-title":"PLoS Med"},{"key":"5432_CR10","volume-title":"WHO guidelines for malaria, 3 June 2022","author":"WHO","year":"2022","unstructured":"WHO. WHO guidelines for malaria, 3 June 2022. Geneva: World Health Organization; 2022."},{"key":"5432_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12936-018-2472-5","volume":"17","author":"K Saravu","year":"2018","unstructured":"Saravu K, Tellapragada C, Kulavalli S, Xavier W, Umakanth S, Brahmarouphu G, et al. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India. Malar J. 2018;17:321.","journal-title":"Malar J"},{"key":"5432_CR12","first-page":"1322","volume":"11","author":"I Chakim","year":"2020","unstructured":"Chakim I, Pumpaibool T. A community-based cross-sectional survey of primaquine adherence in Jambi province, Indonesia. Indian J Public Health Res Develop. 2020;11:1322\u20138.","journal-title":"Indian J Public Health Res Develop"},{"key":"5432_CR13","volume-title":"Guidelines for malaria, 25 November 2022","author":"WHO","year":"2022","unstructured":"WHO. Guidelines for malaria, 25 November 2022. Geneva: World Health Organization; 2022."},{"key":"5432_CR14","volume-title":"Guidelines for malaria, 30 November 2024","author":"WHO","year":"2024","unstructured":"WHO. Guidelines for malaria, 30 November 2024. Geneva: World Health Organization; 2024."},{"key":"5432_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12936-021-03702-5","volume":"20","author":"B Adhikari","year":"2021","unstructured":"Adhikari B, Awab GR, von Seidlein L. Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders. Malar J. 2021;20:164.","journal-title":"Malar J"},{"key":"5432_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:215\u201328.","journal-title":"N Engl J Med"},{"key":"5432_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","volume":"100","author":"S Pal","year":"2018","unstructured":"Pal S, Bansil P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, et al. Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient. Am J Trop Med Hyg. 2018;100:213\u201321.","journal-title":"Am J Trop Med Hyg"},{"key":"5432_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","volume":"394","author":"WRJ Taylor","year":"2019","unstructured":"Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, et al. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019;394:929\u201338.","journal-title":"Lancet"},{"key":"5432_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/cid\/ciy735","volume":"68","author":"CS Chu","year":"2018","unstructured":"Chu CS, Phyo AP, Turner C, Win HH, Poe NP, Yotyingaphiram W, et al. Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in Plasmodium vivax malaria. Clin Infect Dis. 2018;68:1311\u20139.","journal-title":"Clin Infect Dis"},{"key":"5432_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijid.2023.05.063","volume":"134","author":"BR Moore","year":"2023","unstructured":"Moore BR, Salman S, Tobe R, Benjamin J, Yadi G, Kasian B, et al. Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in children. Int J Infect Dis. 2023;134:114\u201322.","journal-title":"Int J Infect Dis"},{"key":"5432_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1802537","volume":"380","author":"A Llanos-Cuentas","year":"2019","unstructured":"Llanos-Cuentas A, Lacerda MVG, Hien TT, V\u00e9lez ID, Namaik-larp C, Chu CS, et al. Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:229\u201341.","journal-title":"N Engl J Med"},{"key":"5432_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12936-021-03959-w","volume":"20","author":"V Ruwanpura","year":"2021","unstructured":"Ruwanpura V, Neukom J, Grietens KP, Price RN, Thriemer K, Lynch CA. Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries. Malar J. 2021;20:428.","journal-title":"Malar J"},{"key":"5432_CR23","volume-title":"Global technical strategy for malaria 2016\u20132030, 2021 update","author":"WHO","year":"2021","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030, 2021 update. Geneva: World Health Organization; 2021."},{"key":"5432_CR24","first-page":"287","volume-title":"Priorities for achieving vivax elimination\u2014a roadmap","author":"CA Lynch","year":"2022","unstructured":"Lynch CA, Shrestha M, Athersuch K, Nowak S, Vidal E, Novoa J, et al. Priorities for achieving vivax elimination\u2014a roadmap. ASTMH: Seattle; 2022. p. 287\u20138."},{"key":"5432_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002970","volume":"4","author":"S Acharya","year":"2024","unstructured":"Acharya S, Shrestha M, Thang ND, Wini L, Habib MN, Neukom J, et al. Optimizing test and treat options for vivax malaria: an options assessment toolkit (OAT) for Asia Pacific national malaria control programs. PLoS Glob Public Health. 2024;4: e0002970.","journal-title":"PLoS Glob Public Health"},{"key":"5432_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280950","volume":"18","author":"M Shrestha","year":"2023","unstructured":"Shrestha M, Neukom J, Acharya S, Habib MN, Wini L, Duong TT, et al. Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts. PLoS ONE. 2023;18: e0280950.","journal-title":"PLoS ONE"},{"key":"5432_CR27","unstructured":"APMEN Vivax working group. Catalyzing change through cross-regional sharing of research and experiences. 2022. https:\/\/apmen.org\/blog\/catalyzing-change-through-cross-regional-sharing-research-and-experiences. Accessed 15 Feb 2025."},{"key":"5432_CR28","doi-asserted-by":"publisher","first-page":"160940691773384","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qualit Methods. 2017;16:1609406917733847.","journal-title":"Int J Qualit Methods"},{"key":"5432_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12936-015-0958-y","volume":"14","author":"The Vivax Working Group","year":"2015","unstructured":"The Vivax Working Group. Targeting vivax malaria in the Asia Pacific: the Asia Pacific malaria elimination network vivax working group. Malar J. 2015;14:484.","journal-title":"Malar J"},{"key":"5432_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/heapol\/czaa166","volume":"36","author":"J Parkhurst","year":"2020","unstructured":"Parkhurst J, Ghilardi L, Webster J, Snow RW, Lynch CA. Competing interests, clashing ideas and institutionalizing influence: insights into the political economy of malaria control from seven African countries. Health Policy Plan. 2020;36:35\u201344.","journal-title":"Health Policy Plan"},{"key":"5432_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/heapol\/czn024","volume":"23","author":"G Walt","year":"2008","unstructured":"Walt G, Shiffman J, Schneider H, Murray SF, Brugha R, Gilson L. \u2018Doing\u2019 health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan. 2008;23:308\u201317.","journal-title":"Health Policy Plan"},{"key":"5432_CR32","volume-title":"Guidelines for malaria, 14 March 2023","author":"WHO","year":"2023","unstructured":"WHO. Guidelines for malaria, 14 March 2023. Geneva: World Health Organization; 2023."},{"key":"5432_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12936-018-2380-8","volume":"17","author":"K Thriemer","year":"2018","unstructured":"Thriemer K, Bobogare A, Ley B, Gudo CS, Alam MS, Anstey NM, et al. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working group. Malar J. 2018;17:241.","journal-title":"Malar J"},{"key":"5432_CR34","unstructured":"Medicines for Malaria Venture. Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of P. vivax malaria. 2020. https:\/\/www.mmv.org\/newsroom\/news-resources-search\/thailand-becomes-first-malaria-endemic-country-asia-pacific-approve. Accessed 15 Feb 2025."},{"key":"5432_CR35","unstructured":"Press release. Tafenoquine approved in Peru [MMV, GSK]. 2021. https:\/\/www.vivaxmalaria.org\/sites\/default\/files\/content\/document\/GSK%20-%20MMV%20PRESS%20RELEASE%20TAFENOQUINE%20APPROVED%20IN%20PERU%20%281%29.pdf."},{"key":"5432_CR36","unstructured":"Ruwanpura VSH, Nowak S, Gerth-Guyette E, Theodora M, Dysoley L, Haile M, et al. Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting. Asia & the Pacific Policy Studies. 2019."},{"key":"5432_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/puar.12475","volume":"76","author":"BW Head","year":"2016","unstructured":"Head BW. Toward more \u201cevidence-informed\u201d policy making? Pub Admin Rev. 2016;76:472\u201384.","journal-title":"Pub Admin Rev"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:51:23Z","timestamp":1749721883000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5432"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05432-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the study protocol was approved by the Human Research Ethics Committee of the Northern Territory Department of Health and Menzies School of Health Research (HREC #22\u20134245). A verbal consent was sought from the meeting participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Bipin Adhikari, Neena Valecha, and Kamala Thriemer are Associate Editors of Malaria Journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}